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Plenary paper
Core binding factors are necessary for natural killer cell development and
cooperate with Notch signaling during T-cell specification
Yalin Guo,1 Ivan Maillard,2 Sankhamala Chakraborti,1 Ellen V. Rothenberg,3 and Nancy A. Speck1
1Department of Biochemistry, Dartmouth Medical School, Hanover, NH; 2Division of Hematology-Oncology, Center for Stem Cell Biology, Life Sciences Institute,
University of Michigan, Ann Arbor; and 3Division of Biology, California Institute of Technology, Pasadena
CBF is the non-DNA binding subunit of
the core binding factors (CBFs). Mice
with reduced CBF levels display pro-
found, early defects in T-cell but not B-
cell development. Here we show that
CBF is also required at very early stages
of natural killer (NK)–cell development.
We also demonstrate that T-cell develop-
ment aborts during specification, as the
expression of Gata3 and Tcf7, which en-
code key regulators of T lineage specifica-
tion, is substantially reduced, as are func-
tional thymic progenitors. Constitutively
active Notch or IL-7 signaling cannot re-
store T-cell expansion or differentiation
of CBF insufficient cells, nor can overex-
pression of Runx1 or CBF overcome a
lack of Notch signaling. Therefore, the
ability of the prethymic cell to respond
appropriately to Notch is dependent on
CBF, and both signals converge to acti-
vate the T-cell developmental program.
(Blood. 2008;112:480-492)
Introduction
T-cell development begins with colonization of the thymus by rare
circulating bone marrow (BM)–derived progenitors,1 which ex-
pand to generate a population of early T lineage progenitors
(ETPs). ETPs then give rise in an orderly fashion to cells
expressing both CD4 and CD8 (double positive (DP)) via several
intermediate CD4/CD8 double negative (DN) stages (DN2, DN3,
and DN4).2 The earliest intrathymic stages of T lineage develop-
ment, proliferation, and survival require signaling through Notch,
c-kit, and the IL-7 receptor, plus the activity of several transcription
factors, including core binding factors (CBFs), Gata3, E2A, c-myb,
Ikaros, TCF/LEF, and Ets family members.2 Notch and the CBFs
were shown to interact genetically in other contexts, although their
genetic hierarchy during T-cell development is unknown.
Natural killer (NK) cells develop in multiple sites, including
liver (fetal and adult), BM, spleen, and thymus.3,4 The first NK
lineage committed progenitors can be identified through their
expression of the interleukin-2 (IL-2)/IL15R chain (CD122)
and the absence of lineage-specific and mature NK cell mark-
ers.3 The differentiation of NK progenitors (NKPs) into imma-
ture and mature NK cells is exquisitely dependent on IL-15
signaling.3 NK-cell development does not require signaling
through the c-kit receptor,3 and sustained Notch signaling
inhibits NK-cell differentiation.5-7 Transcription factors re-
quired for NK-cell development include Ets-1, MEF, Id2,
TCF/LEF, and members of the Ikaros family.3
CBFs are heterodimeric transcription factors consisting of a
DNA binding subunit (Runx1, Runx2, or Runx3) and a non-DNA
binding CBF subunit that increases the affinity of the Runx
subunits for DNA. Homozygous disruption of Runx1 results in a
failure of hematopoietic stem cell (HSC) emergence in the
conceptus,8 and in the adult Runx1 is required for megakaryocyte,
B-cell, and T-cell development.9,10 Conditional deletion of Runx1
in BM progenitors using Mx1-Cre blocked T-cell development at
the DN2 to DN3 transition,9,10 whereas deletion in DN3 cells with
Lck-Cre modestly impaired the formation of DN4 and intermediate
single positive cells.11 Runx1 deletion in DP cells with Cd4-Cre
reduced the number of mature CD4 cells and eliminated a
specialized subset of T cells with NK markers.11,12 However, an
earlier, collective role for CBFs in T-cell development was revealed
by a hypomorphic Cbfb allele (Cbfbrss) that, when carried over a
nonfunctional Cbfb allele, caused an 85% reduction in CBF
protein levels.13 Although HSCs emerged in Cbfbrss/ fetuses and B
cells were generated, there was a profound defect in T-cell
development with what appeared to be consecutive partially
penetrant blocks in the generation of ETPs, DN2, and DN3 cells,
and an almost complete absence of DN4 and DP cells.13
Notch proteins (Notch1-4) are transmembrane receptors that,
on binding the cell surface ligands Delta-like or Jagged, undergo
2 proteolytic cleavages to release the Notch intracellular domain
(ICN).14 ICN translocates into the nucleus, where it binds to the
CSL/RBP-J (CBF1/RBP-J, Suppressor of Hairless, Lag-1) tran-
scription factor, displacing corepressors and recruiting coactiva-
tors of the Mastermind-like (MAML) family. Disruption of
Notch signaling either by conditional deletion of Notch1, by
conditional deletion of CSL, or through expression of a
truncated, dominant negative form of MAML1 completely
blocks T-cell development and results in the generation of
intrathymic B cells.14 Conversely, Notch is sufficient to drive
T-cell development because overexpression of a constitutively
active form of Notch (ICN) leads to T-cell at the expense of
B-cell development at extrathymic sites.14 Exposure of hemato-
poietic progenitors to plate- or cell-bound Notch ligands of the
Delta-like family can drive T lineage development in culture.14-16
In 2 well-characterized examples in hematopoiesis, Notch
signaling was shown to function genetically upstream of the CBFs.
Inactivation of Notch or its ligand Serrate in Drosophila caused the
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loss of Lozenge (a Runx homolog) expression in hemocyte
progenitors,17 and mutations in Notch, Serrate, or Lozenge itself
resulted in a failure to generate the subset of hemocytes called
crystal cells.17,18 In mice, both Notch1 signaling and Runx1 are
required for hematopoietic cell emergence from the aorta/gonad/
mesonephros (AGM) region.8,19-22 Notch1 signaling defects in
mice and zebrafish impair Runx1 expression in the AGM re-
gion,19,20,23 and overexpression of Runx1 in Notch signaling
mutants can rescue the emergence of hematopoietic cells from the
AGM region, demonstrating that Runx1 is, at least in part,
genetically downstream of Notch signaling.23,24
Here we characterized the molecular mechanism underlying the
T-cell defect caused by insufficient CBF levels. We show that
T-cell specification does not occur, as its multiple early markers
(Gata3, Tcf7, Cd3e) fail to be expressed. Notch signaling is not
impaired; and although IL-7 signaling is decreased, it is not solely
responsible for the T-cell defect. Finally, we show that reduced
CBF levels cause an early and profound block in NK-cell
development, which is the first demonstration that the CBFs play
an essential role in the NK-cell lineage.
Methods
Mice
Generation and genotyping of the Cbfbrss (Cbfbtm2.1Spe) and Cbfb (Cbfbtm1Spe)
alleles were described previously.13,25 The animal protocols used in these
studies were approved by our Institutional Animal Care and Use Committees.
Transplant analyses
C57BL/6 (B6.SJL-Ptprc  a  Pep3  b  /BoyJ) x 129S1/SVImJ F1
mice (Ly5.1/Ly5.2) were subjected to 2 split doses of 550 cGy 3 to
4 hours apart. Each recipient received donor fetal liver (FL) and competitor
BM cells (2  105 cells of each) via tail vein injection. All donor fetuses
were of a mixed C57BL/6J and 129S1/SVImJ background and expressed
the Ly5.2 (CD45.2) haplotype. Whole BM competitor cells were prepared
from C57BL/6 (B6.SJL-Ptprc  a  Pep3  b  /BoyJ) (Ly5.1) mice.
Flow cytometry and cell sorting
Flow cytometric analyses were performed on a dual-laser FACSCalibur,
FACSCanto, or on a 4-laser LSRII (BD Biosciences, San Jose, CA). The
following antibodies were purchased from BD PharMingen (San Diego,
CA), eBiosciences (San Diego, CA), or BioLegend (San Diego, CA): CD3
(145-2C11), CD4 (RM4-5), CD8 (53-6.7), CD11b (M1/70), CD11c
(HL3), CD19 (1D3), CD25 (7D4), CD27 (LG.7F9), CD44 (IM7), CD45
(30-F11), B220 (RA3-6B2), Gr-1 (RB6-8C5), CD127/IL-7R (A7R34),
T-cell receptor (TCR; H57-597), TCR	 (GL3), NK1.1 (PK136), CD49b
(DX5), CD122 (TM-b1), CD132 (4G3), NKG2D (CX5), CD45.1 (A20),
CD45.2 (104), Thy1.2 (53.2.1), c-kit (2B8), and pStat5 (47). On the LSRII
platform, doublets were excluded through their FSC-W and SSC-W
characteristics, and 4,6 diamidino-2-phenylindole was used for dead cell
exclusion. The data were analyzed using FlowJo (version 6.1.1, TreeStar,
San Carlos, CA). Cells were sorted on a FACSAria (BD Biosciences).
Cell-cycle analysis
Fetal thymocytes (17.5 days postcoitus (dpc)) were stained with fluorescein
isothiocyanate-conjugated antibodies (CD8, TCR, TCR	, CD11b, Ter119,
B220) and subsequently cultured in Dulbecco modified Eagle medium with
10% fetal bovine serum (FBS) and pulsed with bromodeoxyuridine (BD
Biosciences) for 1 hour. Cells were harvested and stained with anti-
bromodeoxyuridine allophycocyanin, CD45 PerCP-Cy5.5, and 7-amino-
actinomycin D.
In vitro IL-7 stimulation and intracellular staining for TCR,
TCR, and pStat5
Fetal thymocytes (17.5 dpc) were stained with fluorescein isothiocyanate-
conjugated lineage antibodies (CD8, CD3, TCR, TCR	, CD11c, B220,
NK1.1, Mac1, Ter119) as described elsewhere.26,27 Thymocytes were then
incubated at 37°C for 20 minutes in Dulbecco modified Eagle medium with
10% FBS, then treated with 0, 1, and 5 ng/mL IL-7 (PeproTech, Rocky Hill,
NJ) for an additional 20 minutes. At the end of the stimulation, cells were
immediately fixed with 1.6% formaldehyde at room temperature for
10 minutes and permeabilized in ice-cold methanol for 20 minutes. Cells
were stained with phycoerythrin-conjugated anti-phospho-STAT-5 (Tyr694)
plus antibodies to CD44, CD25, and CD45. The analysis of intracellular
TCR staining was performed using the same protocol minus the incubation
and cytokine stimulation.
Enrichment of FL progenitors and OP9 cocultures
Lineage negative (Lin) FL cells (E14.5-E17.5) were isolated by depletion
of Lin (CD19, Gr-1, Ter119, F4/80) cells using MACS LS columns
(Miltenyi Biotec, Auburn, CA). An anti–IL-7R biotin-labeled antibody
was included in the lineage cocktail in experiments in which Notch
signaling was inhibited by 	-secretase inhibitor (GSI).
OP9 and OP9-DL1 cells16 were cultured in Minimum Essential Medium
Alpha supplemented with 20% FBS. Cocultures were performed in 24-well
plates by adding 1 to 5  105 Lin cells to confluent OP9-DL1 monolayers
along with 5 ng/mL human Flt3L and 1 ng/mL murine IL-7 (PeproTech).
IL-6 (1 ng/mL) and 25 ng/mL IL-15 were included in the cultures to
enhance the generation of T, B, and NK cells. Various concentrations of GSI
(InSolution, EMD Biosciences, San Diego, CA) in dimethyl sulfoxide were
added to the cultured cells. Cocultured cells were harvested and analyzed
weekly unless otherwise indicated.
Retroviral infection of hematopoietic progenitors
cDNAs encoding Runx1 (AML1b), the CBF heterodimerization domain
(aa 1-141), full-length CBF, Stat5a, and Stat5aF were subcloned into the
bicistronic MigR1 retrovirus.28 MigR1 expressing the Notch ICN was
previously described.29 Retroviruses were produced in Phoenix cells. One
milliliter of viral supernatant, polybrene (2 ng/mL), and cytokines (IL-7 and
Flt3L) were added to overnight cocultures of Lin FL cells or thymocytes
on OP9-DL1 in 24-well plates and spinoculated at 1400g at room
temperature for 2 hours. The media was changed 24 hours after spinocula-
tion and the coculture continued.
Quantitative RT-PCR
Total RNA was extracted from sorted or unsorted cells using the RNeasy
Mini Kit and DNase I treatment (Qiagen, Valencia, CA). RNA quality was
assessed on agarose gels and quantified by Nano-Drop1000 (Nano-Drop,
Wilmington, DE). First-strand cDNA was generated using reverse transcrip-
tase SuperscriptIII (Invitrogen) and oligo (dT)20 primers. Real-time polymer-
ase chain reaction (PCR) was performed in triplicate on Applied Biosys-
tems’ 7500 Real-Time PCR System (Foster City, CA). Either Taqman
probes or SYBR-Green (Applied Biosystems) were used to detect gene
expression. The following premade mixture of primers and Taqman probes
were used: Runx1 (Mm00486762_m1); Runx3 (Mm00490666_m1); Cbfb
(Mm00491551_m1); Jak1 (Mm00600614_m1); Jak3 (Mm00439962_m1);
Stat3 (Mm00456961_m1); Stat5a (Mm00839861_m1); Stat5b
(Mm00839861_m1); and Hprt1 (Mm00-446968_m1).
The following primers were used for SYBR Green detection: Dtx1 For
TGAGGATGTGGTTCGGAGGT, Rev CCCTCATAGCCAGATGCTGTG;
Hprt For CTCCTCAGACCGCTTTTTGC, Rev TAACCTGGTTCAT-
CATCGCTAATC; Notch1 For CAGCTTGCACAACCAGACAGAC, Rev
ACGGAGTACGGCCCATGTT. Primers for Pu.1, Cd3g, and Cd3e were
described previously.30,31 Absolute quantification of each gene was calcu-
lated by the standard curve method using 10-fold dilutions of a positive
control (spleen cell cDNA). Expression of individual genes was normalized
to Hprt expression.
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Western blot analysis
Green fluorescent protein (GFP) cells were sorted from OP9-DL1
cocultures (purity  99.9%) and resuspended at 105 cells per milliliter in
lysis buffer (150 mM of NaCl, 50 mM of Tris, pH 8.0, 1% Nonidet P-40,
0.5% deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 0.2 mM of
ethylenediaminetetraacetic acid, 2.0 mM of ethyleneglycoltetraacetic acid
plus 1 
g/mL of pepstatin A, 1 
M of Pefablock, 2 
g/mL of leupeptin, 2

g/mL of aprotinin). Lysates were boiled in SDS loading buffer, resolved
by SDS-PAGE through 4% to 12% Bis-Tris gels (Invitrogen), proteins
transferred to nitrocellulose, and the blot probed with a mouse monoclonal
antibody to CBF (141.2).25 The blots were developed with enhanced
chemiluminescence reagents (Pico Kit; Pierce Chemical, Rockford, IL).
Results
The T-cell defect exhibited by Cbfbrss/ cells is recapitulated
ex vivo
We previously assessed the collective role of core binding factors
in hematopoiesis using a hypomorphic allele of the common
non-DNA binding CBF subunit gene (Cbfbrss). Cbfbrss/ FL cells
(expressing 15% of normal CBF levels) contained HSCs that
could contribute to the formation of myelo-erythroid and B lineage
cells, but not to DN4 or DP T cells.13 To further investigate the
molecular basis of this defect, we cultured Lin FL progenitors
from 14.5 to 17.5 dpc mice on OP9 stromal cells expressing the
Notch ligand Delta-like1 (OP9-DL1 cells) to induce T-cell differen-
tiation ex vivo.16 Within 2 weeks after establishing the OP9-DL1
cocultures, Cbfb/ progenitors underwent extensive proliferation
(Figure 1A,B), and approximately half became CD4/CD8 DP
(Figure 1C,D) and gave rise to clear populations of TCR (not
shown) and TCR	 cells (Figure 1E,F). In contrast, the ex vivo
expansion of Cbfbrss/ cells was significantly depressed (Figure
1A,B). Cbfbrss/ progenitors generated very few DP cells (Figure
1C,D), TCR	 cells (Figure 1E,F), or TCR cells (not shown),
and the DN cells contained no detectable intracellular TCR
(Figure 1G). Cbfbrss/rss Lin FL cells, which have higher CBF
levels than Cbfbrss/ cells,13 also produced fewer cells and a
significantly smaller percentage of TCR	 cells (Figure 1B,F);
however, the defects were not as pronounced as those of Cbfbrss/
cells, indicating that T-cell development was affected in a dose-
dependent manner ex vivo.
Cbfbrss/ cells fail to undergo T lineage specification
We examined the DN populations to more precisely define the
T-cell developmental defect caused by reduced CBF dosage.
After 7 days of culture on OP9-DL1, most Cbfb/Lin FL cells
had progressed to the DN2 and DN3 stages, whereas the
majority of Cbfbrss/ cells were arrested before the DN2 stage
(Figure 2A,B). Thymocytes from 16.5 to 17.5 dpc Cbfbrss/
fetuses also exhibited an early T-cell developmental arrest, but a
higher percentage of thymocytes appeared to progress to the
DN2 and DN3 stages (Figure 2C,D). We suspect that the lower
numbers of phenotypic DN2 and DN3 cells generated ex vivo
may be caused by differences in the quality or intensity of
signaling provided by OP9-DL1 cells compared with thymic
stromal cells.
We examined Cbfbrss/ DN cells for molecular markers of
T-cell differentiation. Thy1.2 DN1 thymocytes were present in
Cbfbrss/ 17.5 dpc fetuses, but in significantly reduced numbers
(Figure 2E). Cbfbrss/ DN thymocytes contained no intracellular
TCR or TCR	 chains, which are normally found in DN3 and
DN4 cells, respectively,32 indicating that development arrested
before the commitment stage (Figure 2F). The ex vivo defect
was more pronounced, as Thy1.2 cells were absent in the DN1
population (Figure 2E), although most thymocytes that pro-
gressed to the DN2 stage did express Thy1.2 (Figure 2G). Cd3e
expression, which can normally be found in both DN1 and DN2
cells,33 was essentially undetectable in Cbfbrss/ DN2 cells
purified from the OP9-DL1 cultures, and Cd3g mRNA levels
were significantly reduced (Figure 2H). Gata3 and Tcf7 expres-
sion progressively increased in wild-type DN1 (Figure 2I) and
DN2 (not shown) cells over a 5-day culture period30 but
remained low and unchanged in Cbfbrss/ DN1 and DN2 cells.
PU.1 expression was not elevated in the Cbfbrss/ DN1 popula-
tion, suggesting that respecification into myeloid lineage cells
had not occurred.30
To determine whether Cbfbrss/ fetuses contained functional
thymic progenitors, we attempted to rescue T-cell development
by reintroducing CBF into Cbfbrss/ thymocytes. Although we
could successfully rescue the formation of DP, TCR	, and
DN2-DN4 cells after retroviral transduction of CBF into Lin
Cbfbrss/ FL progenitors (Figure 2J,K), we could not efficiently
rescue T-cell development from Cbfbrss/ fetal thymocytes
(Figure 2L). We could transduce wild-type thymocytes with
GFP-expressing retroviruses and recover GFPCD45 and
GFPDP cells; thus, our retroviral transductions were effective.
However, we could recover only very few GFPCD45 cells
from Cbfbrss/ thymocytes transduced with a bicistronic virus
expressing both CBF and GFP, although these included DP
cells (Figure 2L). Cbfbrss/ DN thymocytes were actively
cycling (Figure 2M,N); thus, it is unlikely that our failure to
rescue T-cell development is the result of a lack of cells
permissive for retroviral transduction. We conclude that Cbf-
brss/ thymi contain very few functional T-cell progenitors.
Altogether, these data indicate that Cbfbrss/ cells have a global,
early defect in T-cell specification.
IL-7 signaling and c-kit expression in Cbfbrss/ cells
We determined whether CBF insufficiency affected the expres-
sion or activity of one or more signaling pathways required at early
stages of T-cell development. IL-7 signaling is essential at the DN1
and DN2 stages, and cell surface IL-7R levels become elevated at
the DN2 stage.34-38 CBFs directly activate the Il7ra (IL-7R) gene
at later stages of T-cell differentiation, in DP and CD4 cells.11,39
We found that the mean fluorescence intensity (MFI) of IL-7R
(CD127) staining was comparable in Cbfb/ and Cbfbrss/ DN2
thymocytes, and that of the common gamma chain (	c/IL2RG/
CD132) was approximately 2.5-fold higher (Figure 3A). However,
the levels of mRNAs encoding several IL-7 signaling molecules,
including Jak1, Stat5a, and Stat5b, were significantly (2 fold)
lower in Cbfbrss/ DN2 cells (Figure 3B) and intracellular pStat5
levels were decreased by approximately 7-fold (Figure 3C).
Decreased JAK/STAT signaling, however, cannot be solely respon-
sible for the T-cell expansion or differentiation defects, as neither
could be reversed on expressing a wild-type or constitutively active
form of Stat5a40 (Figure 3D).
c-kit signaling is also critical for the proliferation and
differentiation of DN1 and DN2 cells.38,41 We found that neither
the percentage of c-kit DN1 thymocytes nor the MFI of c-kit
staining was altered in Cbfbrss/ fetuses (Figure 3E). The
percentage of c-kit cells and staining intensity was also similar
in Cbfb/ and Cbfbrss/ DN1 cells derived from OP9-DL1
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cultures (Figure 3F). Therefore, the T-cell defect does not appear
to be caused by reduced cell surface c-kit expression, although
deficiencies in c-kit signaling were not examined and cannot be
ruled out.
Notch signaling is active in Cbfbrss/ cells
To examine the ability of Cbfbrss/ progenitors to receive Notch
signals, we purified the DN1 population from OP9-DL1 cocultures
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Figure 2. T-cell specification fails to occur in Cbfbrss/ cells. (A) Lin FL cells cocultured on OP9-DL1 in the presence of Flt3L and IL-7 for 7 days. CD8Gr-1GFP cells
(GFP gating was used to eliminate OP9-DL1) were analyzed for CD44 and CD25 expression. (B) Percentages of DN1, DN2, and DN3 cells (from panel A) averaged from
12 independent experiments. Error bars represent SEM. *indicates significant difference (P  .01) between the percentages of Cbfb/ and Cbfbrss/ cells. (C) CD45 Lin
(Lin  CD8, CD3, TCR, TCR	, CD11c, B220, Mac1, NK1.1, Ter119) 17.5 dpc fetal thymocytes analyzed for CD44 and CD25 expression. (D) Data from 6 animals of each
genotype (from panel C). *indicates significant difference (P  .03) between the percentages of Cbfb/ and Cbfbrss/ cells. (E) Expression of cell surface Thy1.2 on 17.5 dpc
DN1 (LinCD45CD44CD25) thymocytes, and on DN1 cells (CD8Gr-1CD45CD44CD25) from day 6 OP9-DL1 cultures. The thymocyte data were averaged from
4 Cbfb/ and 4 Cbfbrss/ fetuses, and the culture data were averaged from 4 Cbfb/ and 3 Cbfbrss/ fetuses. *indicates significant difference (P  .01) between Cbfb/ and
Cbfbrss/ samples. (F) Percentage of 17.5 dpc DN thymocytes (CD45 Lin, Lin  CD8, CD3, CD11c, B220, Mac-1, Ter119) expressing intracellular TCR (iTCR) and iTCR	.
Data are averaged from 3 Cbfb/ and 3 Cbfbrss/ fetuses. (G) Percentage of Thy1.2 DN2 cells after 7 days of OP9-DL1 culture. (H) Cd3e and Cd3g expression by qRT-PCR
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at days 3, 4, and 5 and quantified the expression of Notch1 and
several of its target genes by quantitative RT-PCR (qRT-PCR;
Figure 4A). Notch1 was expressed in Cbfbrss/ cells at all time
points examined, although its levels were reduced approximately
2-fold in freshly isolated “DN1” (ie, LinCD45 CD44CD25)
FL cells (day 0) and in DN1 cells isolated after 3 days of culture on
OP9-DL1 cells, and slightly more than 2-fold at days 4 and 5 of
culture. Expression of the Notch1 target genes Hes1 and Hes5 was
reduced less than or equal to 2-fold in Cbfbrss/ DN1 cells at all
time points examined (Figure 4A). Deltex1 (Dtx1) expression is
known to be a very sensitive indicator of Notch signaling42-44 and
was reduced almost 10-fold in Cbfbrss/ DN1 cells by days 4 and 5
in DN2 cells sorted from day 7 OP9-DL1 cultures (culture conditions and staining as described in panel A). The purity of postsort populations was more than 95%. Expression of
individual genes was normalized to Hprt. Data were derived from triplicate amplifications from 3 independent samples. *indicates significant difference (P  .01) between
Cbfb/ versus Cbfbrss/ values. (I) Lin FL cells cultured on OP9-DL1 cells, harvested at indicated time points. DN1 cells (LinCD45CD44CD25) were isolated by cell
sorting (purity  95%). The expression of individual genes was normalized to Hprt (note log scale for Tcf7) and displayed as relative to day 0 values of Cbfb/ DN1 cells.
Values are averaged from triplicate samples isolated from 3 independent experiments. *indicates significant difference (P  .05) between Cbfb/ versus Cbfbrss/ values.
(J) Rescue of T-cell development with CBF in 17.5 dpc Cbfbrss/ FL cells. Lin FL cells (E17.5) were transduced with the indicated retroviruses and cocultured on OP9-DL1.
Cells were harvested after 2 weeks and GFPCD45 cells analyzed for CD4 and CD8 expression (top panels) and TCR	 expression (middle panels). The bottom 2 plots are
DN cells analyzed after 1 week of coculture. Gated GFPLinCD45 cells were analyzed for expression of CD44 and CD25 (nexperiments  11). (K) Western blot showing CBF
(p22) protein levels resulting from retroviral expression relative to endogenous protein levels, in whole cell extracts prepared from GFPCD45 cells purified from the OP9-DL1
cultures of Lin FL cells (CD45 cell purity  99.9%). The blot was probed with a monoclonal antibody to CBF. The 2 endogenous CBF isoforms generated as a result of
alternative splicing (p21.5 and p22) are both visible on this gel. Samples were normalized for actin expression, and the relative amounts of CBF determined from a dilution
series (not shown). CBF levels in retrovirally transduced cells were 5-fold higher than endogenous levels. Lane 1, Cbfbrss/  MigR1; lane 2, Cbfbrss/  CBF; lane 3,
Cbfb/  MigR1; lane 4, Cbfb/  CBF. (L) Inefficient rescue of T-cell development on restoring CBF expression in 17.5 dpc Cbfbrss/ thymocytes. Thymocytes were
transduced with the indicated retroviruses and cocultured for 7 days on OP9-DL1. Gated GFPCD45 cells were analyzed for CD4 and CD8 expression in the plots below.
GFPCD45 cells are predominantly OP9-DL1 cells.16 (M) Cell-cycle status of CD45 Lin (Lin  CD8, TCR, TCR	, CD11b, Ter119, B220) 17.5 dpc fetal thymocytes.
(N) Summary of cell-cycle data from 5 individual samples per genotype. The differences between Cbfb/ and Cbfbrss/ cells in G0/G1 and G2/M were significant at P  .01.
Figure 3. JAK/STAT and c-kit signaling in Cbfbrss/ T cells. (A) Expression of IL-7R (CD127) and 	c (IL2RG/CD132) on the DN2 thymocytes from Figure 2C (17.5 dpc).
Data are representative of 4 experiments. (B) DN2 cells were sorted from OP9-DL1 cultures (culture conditions and staining as described in Figure 2A). The purity of postsort
populations was more than 95%. Expression of individual genes was normalized to Hprt. Values are averaged from triplicate samples from 3 independent experiments.
*indicates significant difference (P  .05). (C) pStat5 levels in 17.5 dpc DN2 thymocytes on ex vivo stimulation with 0, 1, and 5 ng/mL IL-7 for 20 minutes. Shown is the MFI of
the difference between pStat5 under IL-7–stimulated and nonstimulated conditions. The data are averaged from 5 Cbfb/ and 5 Cbfbrss/ fetuses. Differences are significant at
P  .001. (D) Rescue of T-cell development from Cbfbrss/Lin FL cells with CBF, but not wild-type or constitutively active Stat5a (S711F; Stat5aF), or MigR1 alone ()
(n  5). Cells were harvested after 2 weeks. The expansion of Cbfbrss/ cells (left graph) is calculated by dividing the number of GFP cells on day 14 by that on day 7 of culture.
Only CBF expression significantly (*P  .001) increased cell numbers compared with MigR1-transduced Cbfbrss/ cells. The right-hand graph shows the percentage of GFP
cells expressing CD4 and CD8. (E) Expression of cell surface c-kit on 17.5 dpc DN1 cells. Bar graph on left is the percentage of c-kit DN1 (Lin as in Figure 2B;
CD45CD44CD25) thymocytes, and on right is the MFI of c-kit staining on c-kit DN1 thymocytes. The data are averaged from 4 Cbfb/ and 4 Cbfbrss/ fetuses.
(F) Percentage of DN1 (CD44CD25CD45 Lin) cells expressing surface c-kit and MFI of c-kit staining on c-kit DN1 cells after 6 days of OP9-DL1 culture. The data are
averaged from 4 Cbfb/ and 3 Cbfbrss/ fetuses.
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of culture. Although this is a substantial decrease, Dtx1 levels did
indeed increase in Cbfbrss/ DN1 cells approximately 100-fold
during the culture period. Thus, although there were significant
reductions in the expression of Notch1 and several of its target
genes, the fact that their expression was not completely absent and
was significantly induced after exposure to Notch ligands sug-
gested that Notch signaling was active in Cbfbrss/ cells. Differ-
ences in the initial composition of the DN1 population that could
change further over the culture period could account for the relative
decreases in the levels of Notch1 and its targets because of
enrichment of the Cbfb/ (but not the Cbfbrss/) DN1 population
for T lineage–specified cells.
To determine whether Notch signaling was functionally intact,
we treated OP9-DL1 cocultures with a GSI to block Notch
signaling. When Notch signaling is blocked in wild-type progeni-
tors, B cells will develop at the expense of T cells.45,46 Because
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Figure 4. Notch signaling is active in Cbfbrss/ cells and NK-cell development is defective. (A) Lin FL cells cultured on OP9-DL1 cells, harvested at indicated time points,
and stained with antibodies as described in Figure 2A. DN1 cells (LinCD45CD44CD25) were isolated by cell sorting (purity  95%). The expression of individual genes
was normalized to Hprt (note log scale for Dxt1) and displayed as relative to day 0 Cbfb/ DN1 cells. Values are averaged from 9 samples (triplicate samples from
3 independent experiments). *indicates significant difference (P  .05) between Cbfb/ versus Cbfbrss/ values. (B) Flow cytometric analysis of Lin FL cells cultured on
OP9-DL1 ( Flt3L, IL-7, IL-6, IL-15) in the absence and presence of the gamma secretase inhibitor (GSI) inhibitor X for 7 days. GFPCD45 cells were analyzed for expression
of NK1.1 (NK cells) and CD19 (B cells). nexperiments  7. (C) LinCbfb/ 14.5 dpc FL cells transduced with either MigR1 or a retrovirus expressing the Notch1 intracellular
domain (ICN) and cultured for 7 days on OP9 stromal cells in the presence of Flt3L and IL-7. CD8CD19Gr-1 cells were gated for GFP expression in the left-hand panels,
and GFP cells analyzed for CD44 and CD25 expression in the right-hand panels. (D) LinCbfbrss/ FL cells transduced with MigR1 or ICN, and analyzed as in panel C.
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OP9-DL1 cocultures of Cbfbrss/Lin cells did not contain CD19
B cells (Figure 4B), nor were B cells detected in thymi of mice
transplanted with Cbfbrss/ FL cells,13 this suggested that Notch
signaling was actively repressing B-cell development. As expected,
inhibition of Notch signaling with 1 
M and 3 
M GSI resulted in
the differentiation of CD19 B cells from Cbfb/Lin cells
(Figure 4B). GSI even more efficiently induced the formation of
B cells from Cbfbrss/Lin cells, confirming that Notch1 signaling
was sufficiently active in Cbfbrss/ cells to repress B-cell fate
(Figure 4B). An increase in NK1.1 NK cells was also observed in
Cbfb/ cocultures treated with GSI, but not in Cbfbrss/ cocultures.
Thus, Cbfbrss/ cells had a defect in NK-cell development, which
will be discussed in more detail later.
Although Notch signaling in Cbfbrss/ cells was adequate to
suppress B-cell development, higher levels of Notch signaling are
required to drive T-cell development.7 Therefore, to confirm that
the lower levels of Notch1 or other defects in Notch signaling were
not the underlying cause of the T-cell developmental defect, we
transduced Cbfbrss/Lin FL cells with a retrovirus expressing the
constitutively active intracellular form of Notch1 (ICN). Cbfb/
cells expressing high levels of ICN (based on the surrogate GFP
marker) efficiently differentiated into DN2 and DN3 cells after
7 days of culture on OP9 cells (Figure 4C). On the other hand,
Cbfbrss/ progenitors expressing ICN grew poorly, giving rise to a
low percentage of GFP cells (1.7%  0.5% vs 66.6%  15.0%
for Cbfb/ cells), and only a few of those cells differentiated to
and past the DN2 stage (Figure 4D). Thus, constitutively high
levels of Notch signaling did not rescue T-cell development but
instead selected against the growth or survival of Cbfbrss/ cells.
Because high levels of Notch signaling efficiently block B- and
NK-cell development,47 and T-cell development from Cbfbrss/
progenitors could not be rescued by ICN, the ICN-expressing
Cbfbrss/ cells could not differentiate into the T-, NK-, or B-cell
lineages and appeared to be selected against, thus yielding rela-
tively few GFP cells in the cultures. Therefore, the moderate
decrease in Notch1 expression, or potential defects in ligand
binding or cleavage of the Notch receptor are unlikely to be
responsible for the Cbfbrss/ early T-cell defect but indeed may be
selectively enriched to permit survival of the Cbfbrss/ cells.
Runx1, Runx3, and CBF expression are not dependent on
Notch signaling
Runx1 expression is activated by Notch signaling during hemato-
poietic stem cell development19,20,23,24; thus, we determined whether
Runx1, Runx3, or Cbfb expression in T cells also required Notch
signaling. Addition of 1 
M and 3 
M GSI to Cbfb/ OP9-DL1
cocultures impaired the differentiation of DN2 and DN3 cells in a
dose-dependent manner (Figure 5A). Expression of the Notch1
targets Hes1 and Dtx1 was significantly decreased in DN1 cells, as
was Gata3 and Tcf7 (Figure 5B), demonstrating that Notch
signaling and T-cell development were indeed inhibited at the
3 
M GSI concentration. However, Runx1, Runx3, and Cbfb
expression did not significantly change in DN1 cells in the presence
of GSI, consistent with the conclusion that none of these genes is a
downstream activated target of Notch1 in early T lineage progeni-
tors (Figure 5B). Because heterogeneity of the DN1 population
could obscure modest changes in gene expression, we purified
c-kitCD27CD25 lymphoid progenitors from the DN1 popula-
tion30 and assessed Runx1 expression (Figure 5C). Inhibition of
Notch signaling with 3 
M GSI resulted in a small but significant
increase in Runx1 mRNA levels in c-kitCD27CD25 cells,
confirming that Runx1 expression in lymphoid progenitors does
not require Notch signaling. Moreover, retroviral overexpression of
neither Runx1 (Figure 5D) nor CBF (not shown) in Cbfb/
progenitors treated with 3 
M GSI could rescue the perturbation in
T-cell development caused by inhibition of Notch signaling,
supporting the hypothesis that blocking Notch signaling does not
impair T-cell development by affecting Runx1, Runx3, or Cbfb
expression. In summary, the activity of the Notch pathway does not
depend on the CBFs, nor does CBF expression require Notch
activity. Rather, Notch and CBF expression and activity are
independently regulated in uncommitted thymic progenitors and
converge to specify the T-cell lineage.
CBF is required for NK-cell development
Although Cbfbrss/ Lin cells were capable of producing B cells,
we observed a defect in NK-cell development when Notch
signaling was inhibited (Figure 4B). We examined this more
directly by culturing Lin FL cells on OP9 stromal cells in the
presence of Flt3L, IL-7, and IL-15. CD122 (IL2R) is a subunit of
the IL-15 receptor and is regulated by the CBFs.48 Cbfb/Lin FL
cells generated a large number of CD122 cells, including
NK1.1CD122 NK cells and NK1.1CD122 NKPs. Cbfbrss/
Lin FL cells, on the other hand, produced very few CD122 cells
(Figure 6A,B) that would be capable of responding to IL-15
signaling. These data indicate that ex vivo NK-cell development
from fetal liver cells was blocked very early, before the NKP stage.
To assess whether there was also an in vivo NK-cell defect, we
examined thymi from 15.5 dpc Cbfbrss/ fetuses for NK cells.
Bipotent T/NK progenitors and mature NK cells in the fetal thymus
both express NK1.1.49 Cbfbrss/ fetal thymi contained very few
NK1.1 (or NK1.1CD122) cells (Figure 6C,D), indicating that
almost no mature NK cells or bipotent T/NK progenitors were
present. We also examined mice transplanted with Cbfb/,
Cbfbrss/rss, and Cbfbrss/ 17.5 dpc FL cells13 for the presence of
donor-derived NK cells. As expected, there were no or very few
donor-derived T cells in the BM or spleen of mice transplanted with
Cbfbrss/ FL cells (Figure 6E,F). Donor-derived mature NK cells
were present in the peripheral blood (not shown), BM (Figure 6E),
spleen (Figure 6F), and thymus (not shown) of transplant recipients
of Cbfb/ and Cbfbrss/rss FL cells. However, Cbfbrss/ donor-
derived mature and immature NK cells (NK and iNK) were
completely absent in recipients reconstituted with Cbfbrss/ FL cells
(Figure 6E,F). We also observed a decreased contribution of
Cbfbrss/ FL cells to CD19 B cells in the BM, but this decrease
was not observed in the spleen, suggesting peripheral compensa-
tion for a partial defect in BM B-cell development (Figure 6E,F).
The precipitous decline in NK-cell development that occurred
when the CBF concentration dropped from 30% (Cbfbrss/rss) to
15% (Cbfbrss/) of normal levels mirrored the abrupt and profound
T-cell defects we observed at this same transition,13 indicating that
both early T- and NK-cell development requires a similar threshold
level of CBF. We also examined the transplant recipients for
committed NKP (Figure 6G). The percentage of donor-derived NK
cells and their precursors in both BM and spleen of the transplant
recipients was lower than in the C57BL/6 (B6) control, perhaps
because of the more advanced age of the transplant recipients. This
precluded evaluation of donor-derived NKP in the BM; however,
we were able to detect NKP in the spleen. Mice transplanted with
Cbfb/, Cbfbrss/rss, and Cbfbrss/ FL cells all contained a detectable
population of NKP in their spleen (Figure 6G). Therefore, the NK-
cell deficiency in transplanted adult mice occurred at the NKP to
iNK transition, whereas in the fetal liver and thymus it preceded the
emergence of NKP.
CBFs IN EARLY T- AND NK-CELL DEVELOPMENT 487BLOOD, 1 AUGUST 2008  VOLUME 112, NUMBER 3  use only.
For personal at CALIFORNIA INST TECH/MILLIKAN LIBRARY on July 25, 2008. www.bloodjournal.orgFrom 
We (and others) examined the expression of core binding factor
genes in iNK and NK cells purified from wild-type mice to
ascertain which members of the Runx family might be required in
NK cells.48 Runx1, Runx3, and Cbfb mRNA were all found in
LinSca-1c-kit BM progenitors, iNK, and NK cells, and both
Runx3 and Cbfb mRNA levels increased during NK-cell differ-
entiation (Figure 6H). Runx2 mRNA levels were very low in
LinSca-1c-kit, iNK, and NK cells (not shown). Based on
expression levels, we predict that Runx1 and/or Runx3 are the
Runx subunits most likely to be involved in NK-cell development.
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Figure 5. Inhibition of Notch signaling does not affect Runx1, Runx3, or Cbfb expression. (A) Flow cytometric analysis of Lin FL cells cultured on OP9-DL1 in the
absence and presence of the indicated concentrations of GSI for 7 days. CD8CD19Gr-1GFP cells were analyzed for CD44 and CD25 expression (nexperiments  8).
(B) Gene expression profile of DN1 cells sorted from day 7 OP9-DL1 cocultures treated with dimethyl sulfoxide (), 1.0 
M GSI ( ), or 3.0 
M GSI (f). Cell sorting, RNA
preparation, and real-time PCR were performed as described for Figure 4A. Taqman probes were used for the quantification of Runx1, Runx3, Cbfb, and Hprt, and SYBR green
was used for the remainder of the genes. Expression of each gene was quantified in comparison to a standard curve prepared with dilutions of spleen cDNA. The expression of
individual genes is displayed relative to Hprt. Data are averaged from 4 independent experiments. Error bars represent SEM. *indicates significant difference (P  .05)
between GSI-treated and untreated cells. (C) Runx1 expression in lymphoid progenitors (c-kitCD27CD25) isolated from day 3 OP9-DL1 cultures in the absence and
presence of 3 
M GSI (averaged from triplicate samples from 3 independent experiments). The increase in Runx1 expression in GSI-treated cultures was significant at
P  .01. (D) Ectopic expression of Runx1 in Cbfb/ FL cells cultured on OP9-DL1 in the absence and presence of GSI at 3 
M. Analysis was performed as in panel A.
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Figure 6. CBF is required at an early stage of NK-cell development in vivo. (A) Representative scatter plots of Lin 15.5 dpc FL cells grown on OP9 cells in the presence of
Flt3L, IL-7, and IL-15. Gr-1CD19 cells were analyzed for CD122 and NK1.1 expression. (B) Percentage and absolute number of CD122 cells ( SD) harvested from OP9 cultures
established from 3 Cbfb/ and 4 Cbfbrss/ fetuses (nexperiments 3). (C) NK cells in 15.5 dpc fetal thymi. (D) Total number of thymic NK1.1 and NK1.1CD122 cells averaged from
3 Cbfb/ and 3 Cbfbrss/ fetuses (nexperiments 3). (E-G) Lethally irradiated CD45.1 CD45.2 F1 recipients were reconstituted with wild-type CD45.1 BM and CD45.2 FL cells from
Cbfb/, Cbfbrss/rss, or Cbfbrss/ fetuses (expressing 100%, 30%, and 15% of normal CBF levels, respectively). (E) Bone marrow of recipient mice analyzed 10 months after reconstitution.
The data are from gated FL-derived (CD45.2) progenitors. A representative example is shown in each group (Cbfb/, n 4; Cbfbrss/rss, n 4; Cbfbrss/, n 5). Bone marrow from a
10-week-old C57BL/6 (B6) mouse is shown as control. CD19CD3TCRNK1.1DX5 cells are mature NK cells, whereas immature NK lineage cells (iNK) have a NK1.1Dx5
phenotype. (F)The spleen of recipient mice analyzed in a similar way, illustrating the absence of immature and mature NK cells among cells derived from Cbfbrss/progenitors. (G) Primitive
NK lineage committed progenitors (NKP) (CD122/IL2RNKG2DNK1.1Dx5LinT) (LinT CD3CD4CD8TCRTCR	) are preserved in the spleen of recipient mice. NKP express
the IL-2/IL-15R chain and have an NK1.1Dx5CD19CD3CD4CD8aTCRTCR	 phenotype. A fraction of these cells expresses NKG2D.3 (H) Expression Runx1, Runx3, and
Cbfb by qRT-PCR in LSK (Lin CD4, CD8, TCR, TCR	, DX5, CD19, Mac-1, Ter119), iNK (CD4CD8TCRTCR	CD19CD49bNK1.1CD122) and mature NK
(CD4CD8TCRTCR	CD19CD49bNK1.1CD122) cells sorted from BM of 8- to 12-week-old wild-type mice. The purity of post-sort populations was more than 98%. Expression
of individual genes was normalized to Hprt. * Significant difference (P .01) from LSK cell values.
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Discussion
The CBFs and Notch cooperate in early T-cell development
We endeavored to define the molecular mechanisms underlying the
requirement for CBFs in early T-cell development by examining
the expression of T-cell specific genes, and signaling pathways
important for T-cell development in mice with reduced CBF
levels. A small percentage of Cbfbrss/ cells reached the DP stage of
T-cell development when cultured on OP9-DL1 stromal cells,
although the absolute number of cells that progressed past the DN1
stage was extremely low. The majority of Cbfbrss/ cells expressed
very little, if any, Cd3e, Gata3, or Tcf7 mRNA, and no intracellular
TCR	 or TCR chains were present. Thus, Cbfbrss/ cells lacked
some of the earliest and most critical mediators of T-lineage
development, indicating that T-lineage specification had essentially
failed to occur. Although Cbfbrss/ cells were competent to receive
Notch signals and by virtue of that were restrained in their ability to
undergo B-cell development, they could not integrate the Notch
signal to fully activate the T-lineage program. Thus, CBFs are
needed to establish a T-lineage inducible state that is competent to
respond to Notch signaling.
The mechanisms by which the CBFs and Notch signaling
converge to specify T cells are unknown. One possibility is that
they integrate at the level of common target genes in ETPs and at
subsequent stages of DN thymocyte development. A few bona fide
direct Notch targets are known in mammals, the best examples of
which are the Hairy/Enhancer of SPLIT (HES) genes.50 Although
no HES genes have been implicated as direct CBF targets, the
mammalian HES-1 protein has been shown to physically interact
with both Runx1 and Runx2, and HES-1 can potentiate Runx2
transactivation in reporter assays.51 Thus, one mechanism by which
Notch and CBFs may integrate their function is through the direct
interaction of Runx and HES proteins. Genes, such as Il2ra, which
encode the CD25 molecule, could be directly and coordinately
regulated by Notch and the CBFs.39,43,52
Our observations during T-cell development contrast with the
initial stages of hematopoiesis in vertebrates, where Runx1 expres-
sion is dependent on Notch1 signaling (Figure 7), and overexpres-
sion of the mammalian or zebrafish Runx1 protein could rescue
hematopoiesis from the AGM region in Notch mutant ani-
mals.19,20,23,24,53 In contrast, neither Runx1 nor CBF expression
was decreased, nor could overexpression of Runx1 or CBF
restore T-cell development when Notch signaling was inhibited.
Defects in both early T-cell and NK-cell development implicate
pathways essential for both lineages
Although we could restore T-cell development when we overex-
pressed CBF in Cbfbrss/ Lin FL cells, we were unable to
efficiently restore proliferation or T-cell differentiation from Cbfbrss/
thymocytes. One possible explanation for this failure is that the
defect may originate in a prethymic T-cell progenitor, and as a
result very few of them emigrate to the thymus or they fail to
proliferate or survive once they arrive. The majority of T-cell
progenitors in the fetal liver and thymus have both T- and NK-cell
potential,54-58 and a defect within this population could also account
for the lack of NK cells we observed in OP9 cultures of fetal liver
cells and in the fetal thymus. Both the T- and NK-cell defects
became pronounced when CBF levels were reduced from 30% to
15% of normal levels, consistent with the hypothesis that they be
ultimately traced, in part, to perturbations in the expression of
genes required in both lineages, or to a common progenitor.
Preliminary data indeed suggest that 12.5 dpc Cbfbrss/ fetal livers
contained 6- to 7-fold fewer phenotypic (c-kitCD127PIR-A)
trilineage T-, NK-, and dendritic cell (T/NK/DC) progenitors55 (not
shown). Furthermore, fetal thymi contained only very low numbers
of NK1.1 cells, which include all the bipotent T/NK progenitors
and mature NK cells.49 The small number of Cbfbrss/ T/NK
progenitors that do colonize the thymus may, in addition, be
functionally defective, perhaps because they have undergone
irreversible epigenetic changes or were unresponsive to the cyto-
kines (Flt3L and IL-7) that we used in the transduction cocktail.
The NK-cell defect in the transplanted adult mouse appeared to
occur somewhat later, at the transition between NKP and iNK cells.
NKP differentiate from the HSC through intermediate precursors
that have not been unambiguously identified, but may include the
early and common lymphoid progenitors (ELP and CLP), both of
which are distinct from the fetal liver T/NK progenitor.3 Because
B-cell development in Cbfbrss/ mice is only mildly affected, the
ELP and CLP are presumably present, and are apparently able to
give rise to NKP.
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Figure 7. Genetic interactions between the CBFs and Notch signaling in the specification of HSCs, T cells, and NK cells in the fetus. Notch receptors and ligands are
expressed on the aortic endothelial cells in the AGM region that give rise to HSCs.20 Notch signaling is required for Runx1 expression in endothelial cells and for the formation of
HSCs19,20,23,24; thus, Notch is genetically upstream of Runx1 in HSC formation.O represent molecular interactions; represent cell migrations. PB indicates peripheral blood.
HSCs and progenitors are released into the circulation from their sites of formation and colonize the fetal liver. We speculate that Runx1 and/or Runx3 plus CBF are required
to generate NKP from either a bipotent T/NK or another progenitor in the fetus, and perhaps in T/NK progenitors themselves. CBFs are also required for the NKP to iNK
transition, based on data from the adult. Circulating progenitors expressing all 3 CBF complexes colonize the thymus where they encounter high levels of Notch ligands. CBFs
confer on these progenitors the ability to respond to Notch signaling, which results in T-cell specification and progression to the ETP/DN2 stage accompanied by the expression
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Other transcription factors are necessary for both T- and
NK-cell development, including members of the Ikaros, ETS, Id,
and TCF7/LEF-1 families.59-68 However, mutations in none of
these genes selectively and profoundly affected both T- and NK-
but not B-cell development in mice. The profound T- and NK-cell
defects we observed in Cbfbrss/ mice most closely resemble those
associated with the TBNK forms of severe combined immune
deficiency syndrome in humans, which are caused by mutations
that affect both the IL-7 and IL-15 signaling pathways.69 Molecules
in both pathways are regulated by the CBFs. The CBFs regulate
CD122 (Il2rb) expression in NK1.1 cells, and Runx1 is required
for full activation of the Il7ra gene in DN2, DN3, and DP (TCRhi
CD69) thymocytes and in Foxp3CD4 cells.11,48 We found
essentially no CD122 cells in ex vivo cultures of Cbfbrss/ Lin
cells or in the thymus. IL-7R levels were unchanged in
Cbfbrss/ DN2 cells, but IL-7 signaling was nonetheless compro-
mised, as levels of phosphorylated Stat5 were lower. However,
defective JAK/STAT signaling is unlikely to be the only defect in
Cbfbrss/ T and NK cells. Neither wild-type nor constitutively
active Stat5a could rescue the T-cell abnormalities, indicating that
defective JAK/STAT signaling alone cannot explain the T-cell
defect. Egawa et al11 similarly concluded that defective IL-7
signaling was not the only factor limiting the number of Runx1-
deficient CD4 T cells. Furthermore, the defects in Cbfbrss/ cells
are manifested before the IL-7–dependent stage of T-cell growth, as
their inability to express Cd3e, Gata3, or Tcf7 is consistent with a
profound regulatory defect in T-cell specification. In NK cells
CBFs appear to regulate multiple genes, including the Ly49 family
in mouse and the killer cell Ig-like receptors in human.70,71 In the
future, it will be interesting to explore whether abnormalities in
Runx/CBF function might account for a subset of SCID patients
with as of yet no identified mutations.
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